Zobrazeno 1 - 10
of 353
pro vyhledávání: '"J. P. Fillastre"'
Autor:
Christian Thuillez, F. Le Roy, J. P. Fillastre, Robinson Joannides, N Moore, Michel Godin, Odile Rivault, El.H. Bakkali
Publikováno v:
Nephrology Dialysis Transplantation. 12:2623-2628
BACKGROUND An altered arterial nitric oxide (NO) pathway could partly explain the damage to arteries observed in haemodialyzed (HD) patients. The present study was designed to non-invasively evaluate the NO pathway of peripheral conduit arteries in H
Autor:
Jean-Paul Morin, J. P. Fillastre, Caroline Leclere, Christelle Monteil, Veronika Elkaz, Françoise Dantzer
Publikováno v:
Cell Biology International. 17:953-960
We have assessed the impact of increasing oxygen availability on cellular phenotype expression of rabbit proximal tubule cells in primary culture developed with variable glucose and/or insulin contents. To mitigate hypoxia at the cell/medium interfac
Publikováno v:
Toxicology in vitro : an international journal published in association with BIBRA. 5(5-6)
A primary culture of rabbit kidney proximal tubule cells has been developed from highly purified and calibrated fragments of proximal tubules. Cells are grown without serum in various media. Minimum medium (MM) was composed of glucose-free Dulbecco's
Autor:
Françoise Mignon, R al Khayat, G. Humbert, B Viron, Eric Singlas, J. P. Fillastre, A Sobel, P Chauveau, F Borsa Lebas, J L Poignet, Anne-Marie Taburet, O Parent de Curzon
Publikováno v:
Antimicrobial Agents and Chemotherapy. 36:1519-1524
The pharmacokinetics of didanosine were investigated following oral administration of a single 375-mg dose to eight human immunodeficiency virus-seropositive patients with normal renal function and eight human immunodeficiency virus-seropositive urem
Publikováno v:
European Journal of Clinical Pharmacology. 42:535-538
The pharmacokinetics of IV meropenem (500 mg over 30 min) has been studied in 6 healthy volunteers and 26 patients with various degrees of renal impairment. Blood samples were taken at different times over 24 h in healthy subjects and 36 to 48 h in u
Publikováno v:
European Journal of Clinical Pharmacology. 41:579-583
The pharmacokinetics of cefixime following a single oral dose of 200 mg have been investigated in 6 normal subjects and in 22 patients with various degrees of renal insufficiency. Serum and urine samples were collected between 0 and 72 h and were sub
Autor:
E, Singlas, J P, Fillastre
Publikováno v:
Clinical Pharmacokinetics. 20:389-410
Cardiovascular diseases occur frequently in patients with renal failure. Any pharmacokinetic impairment in these diseases should be considered when individualizing drug therapy. The pharmacokinetics of new cardiovascular drugs in uraemic patients are
Publikováno v:
Antimicrobial Agents and Chemotherapy. 34:17-20
Lomefloxacin pharmacokinetics were investigated in 6 normal subjects and 24 uremic patients after a single oral dose of 400 mg. In subjects with normal renal function, the peak level in plasma averaged 3.5 +/- 0.9 micrograms/ml (mean +/- standard dev